Published in Eur Radiol on July 04, 2012
Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers. Breast Cancer Res (2015) 1.20
Mammographic density, MRI background parenchymal enhancement and breast cancer risk. Ann Oncol (2013) 0.99
Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle. Radiology (2013) 0.90
Background 99mTc-methoxyisobutylisonitrile uptake of breast-specific gamma imaging in relation to background parenchymal enhancement in magnetic resonance imaging. Eur Radiol (2014) 0.85
Background parenchymal uptake during molecular breast imaging and associated clinical factors. AJR Am J Roentgenol (2015) 0.83
Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response. Eur Radiol (2015) 0.82
The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue. Eur Radiol (2013) 0.82
Breast tissue composition and its dependence on demographic risk factors for breast cancer: non-invasive assessment by time domain diffuse optical spectroscopy. PLoS One (2015) 0.80
Does background parenchymal enhancement on MRI affect the rate of positive resection margin in breast cancer patients? Br J Radiol (2014) 0.78
Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer. Oncotarget (2016) 0.77
Relationships between mammographic density, tissue microvessel density, and breast biopsy diagnosis. Breast Cancer Res (2016) 0.75
The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer. Clin Imaging (2015) 0.75
Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging. Radiology (2016) 0.75
Effects of Neoadjuvant Chemotherapy on Benign Breast Lesions Compared to Cancers: Should an Additional Lesion on Magnetic Resonance Imaging Responding Similar to Cancer after Neoadjuvant Chemotherapy be Viewed with Suspicion? J Clin Imaging Sci (2016) 0.75
Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging. Nagoya J Med Sci (2015) 0.75
Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients. Transl Oncol (2017) 0.75
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology (1997) 1.79
A longitudinal study of the effects of menopause on mammographic features. Cancer Epidemiol Biomarkers Prev (2002) 1.78
Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology (2011) 1.74
Screening breast MR imaging in women with a history of chest irradiation. Radiology (2011) 1.53
Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.43
Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology (1997) 1.35
Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am (2007) 1.34
Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol (2011) 1.14
Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol (2008) 1.02
Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations. Radiology (2005) 1.00
Normal parenchymal enhancement patterns in women undergoing MR screening of the breast. Eur Radiol (2011) 0.90
Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res (2004) 0.89
Breast magnetic resonance imaging findings in women treated with toremifene for premenstrual mastalgia. Acta Radiol (2009) 0.82
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med (2006) 7.82
Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered (2003) 5.78
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
Postmenopausal hormone therapy and change in mammographic density. J Natl Cancer Inst (2003) 3.83
Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res (2006) 3.62
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology (2012) 3.36
Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev (2003) 3.11
A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res (2007) 3.08
National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009. J Natl Cancer Inst (2010) 2.59
Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology (2011) 2.41
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer. Ann Intern Med (2010) 2.17
Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol (2009) 2.14
Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol (2006) 2.11
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J (2005) 2.04
Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. J Steroid Biochem Mol Biol (2013) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis (2002) 2.01
Predictors of the timing of natural menopause in the Multiethnic Cohort Study. Am J Epidemiol (2008) 2.01
Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception (2010) 1.96
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort. Hum Mol Genet (2003) 1.88
MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol (2003) 1.84
Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? J Clin Oncol (2002) 1.82
Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res (2007) 1.82
Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Res (2005) 1.76
Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology (2011) 1.74
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet (2005) 1.67
Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol (2002) 1.66
To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy? AJR Am J Roentgenol (2002) 1.64
The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo. Proc Natl Acad Sci U S A (2008) 1.53
Screening breast MR imaging in women with a history of chest irradiation. Radiology (2011) 1.53
Markers of inflammation and risk of ovarian cancer in Los Angeles County. Int J Cancer (2009) 1.52
Shorter androgen receptor CAG repeat lengths associated with cryptorchidism risk among Hispanic white boys. J Clin Endocrinol Metab (2011) 1.50
MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol (2003) 1.50
IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One (2008) 1.50
Green tea and risk of breast cancer in Asian Americans. Int J Cancer (2003) 1.48
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer (2013) 1.47
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet (2010) 1.47
Dietary sources of N-nitroso compounds and bladder cancer risk: findings from the Los Angeles bladder cancer study. Int J Cancer (2013) 1.45
Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am J Epidemiol (2007) 1.44
Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up. Radiology (2011) 1.44
Prospective Study of Alcohol Drinking, Smoking, and Pancreatitis: The Multiethnic Cohort. Pancreas (2016) 1.43
Dynamic NMR effects in breast cancer dynamic-contrast-enhanced MRI. Proc Natl Acad Sci U S A (2008) 1.41
Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol (2002) 1.40
Racial/ethnic differences in endometrial cancer risk: the multiethnic cohort study. Am J Epidemiol (2006) 1.37
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36
The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study. Am J Epidemiol (2005) 1.36
Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev (2009) 1.35
Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology (2003) 1.34
Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet (2013) 1.34
Dietary fiber and colorectal cancer risk: the multiethnic cohort study. Cancer Causes Control (2007) 1.33
Does mammographic density reflect ethnic differences in breast cancer incidence rates? Am J Epidemiol (2004) 1.30
Dense breast stromal tissue shows greatly increased concentration of breast epithelium but no increase in its proliferative activity. Breast Cancer Res (2006) 1.29
Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer (2009) 1.25
Bilateral contrast-enhanced dual-energy digital mammography: feasibility and comparison with conventional digital mammography and MR imaging in women with known breast carcinoma. Radiology (2012) 1.22
Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology (2006) 1.21
Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23. Hum Mol Genet (2013) 1.19
IL-6 levels and genotype are associated with risk of young adult Hodgkin lymphoma. Blood (2003) 1.18
Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging. Radiology (2011) 1.17
Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. Int J Cancer (2011) 1.17
Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res (2006) 1.16
Body size, hormone therapy and risk of breast cancer in Asian-American women. Int J Cancer (2007) 1.15
Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol (2011) 1.14
Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells. Curr Biol (2005) 1.14
Predictors of noncompliance in an oral contraceptive clinical trial. Contraception (2011) 1.13
Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol (2003) 1.13
Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol (2012) 1.13
Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis (2010) 1.12
Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol (2003) 1.12
Established risk factors account for most of the racial differences in cardiovascular disease mortality. PLoS One (2007) 1.12
Invasive breast cancer incidence trends by detailed race/ethnicity and age. Int J Cancer (2011) 1.12
Prostate cancer incidence and intake of fruits, vegetables and related micronutrients: the multiethnic cohort study* (United States). Cancer Causes Control (2006) 1.10
Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. Int J Epidemiol (2013) 1.10
Dietary patterns and breast cancer risk in Asian American women. Am J Clin Nutr (2009) 1.10
Mammographic surveillance after breast conservation therapy. Radiology (2013) 1.09
ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev (2010) 1.08
Role of lipid peroxidation in the epidemiology and prevention of breast cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.08
Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology (2007) 1.07
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev (2006) 1.07
Ensuring high-quality breast MR imaging technique and interpretation. Radiology (2013) 1.07
Imaging findings in phyllodes tumors of the breast. Eur J Radiol (2011) 1.07
Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? AJR Am J Roentgenol (2006) 1.07
Chondral defect repair after the microfracture procedure: a nonhuman primate model. Am J Sports Med (2005) 1.06
Does breast size modify the association between mammographic density and breast cancer risk? Cancer Epidemiol Biomarkers Prev (2008) 1.05
A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr (2005) 1.05
Intravoxel incoherent motion diffusion-weighted MRI at 3.0 T differentiates malignant breast lesions from benign lesions and breast parenchyma. J Magn Reson Imaging (2013) 1.05